Cita APA

de Almeida Carvalho, L. M., de Oliveira Sapori Avelar, S., Haslam, A., Gill, J., & Prasad, V. (2019). Estimation of Percentage of Patients With Fibroblast Growth Factor Receptor Alterations Eligible for Off-label Use of Erdafitinib. JAMA Netw Open.

Citación estilo Chicago

de Almeida Carvalho, Lelia Maria, Sandra de Oliveira Sapori Avelar, Alyson Haslam, Jennifer Gill, y Vinay Prasad. "Estimation of Percentage of Patients With Fibroblast Growth Factor Receptor Alterations Eligible for Off-label Use of Erdafitinib." JAMA Netw Open 2019.

Cita MLA

de Almeida Carvalho, Lelia Maria, et al. "Estimation of Percentage of Patients With Fibroblast Growth Factor Receptor Alterations Eligible for Off-label Use of Erdafitinib." JAMA Netw Open 2019.